Accura Research Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 36.39%
- Profit Growth -1028.17%
- Ebitda -114.31%
- Net Worth -31.19%
- Total Assets -93.22%
About Accura Research Chemicals
Accura Research Chemicals Private Limited (ARCPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2015 and has a history of Ten years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Tungaturthy, Neelam Singla, and Thungathurthi Bhavani serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233TG2015PTC097285
- Company No.
097285
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Accura Research Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Tungaturthy  | Whole-Time Director | 19-Jan-2015 | Current |
| Neelam Singla | Whole-Time Director | 15-Feb-2019 | Current |
| Thungathurthi Bhavani | Whole-Time Director | 19-Jan-2015 | Current |
Financial Performance of Accura Research Chemicals.
Accura Research Chemicals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 36.39% increase. The company also saw a substantial fall in profitability, with a 1028.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accura Research Chemicals?
In 2018, Accura Research Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ventochem Private LimitedVenkata Tungaturthy and Thungathurthi Bhavani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Accura Research Chemicals?
Unlock and access historical data on people associated with Accura Research Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accura Research Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accura Research Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.